FOLH1 and neoplasm: Preclinical studies have demonstrated that TAT with 213Bi labeled antibody J591, small molecule inhibitor PSMA-I&T or nanobody JVZ-008 showed efficient and rapid tumor targeting, induced apoptosis in PSMA-overexpressing cell lines, significantly delayed spheroid growth of xenograft tumor growth in nude mice [81,96,97,98].